|
Market Closed -
Bombay S.E.
06:20:55 2026-10-01 EDT
|
5-day change | 1st Jan Change | ||
| 2,774.50 INR | +0.25% |
|
-1.81% | +12.28% |
| 08-03 | GSK India first-quarter profit rises on steady vaccine demand | RE |
| 08-03 | GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| Market Cap | 470B 4.9B 4.32B 4.09B 3.69B 6.96B 7.05B 48.93B 18.83B 240B 18.41B 18.01B 770B | P/E 2027 * |
40.2x | P/E 2028 * | 35x |
|---|---|---|---|---|---|
| Enterprise Value | 470B 4.9B 4.32B 4.09B 3.69B 6.96B 7.05B 48.93B 18.83B 240B 18.41B 18.01B 770B | EV / Sales 2027 * |
11x | EV / Sales 2028 * | 9.95x |
| Free-Float |
24.37% | Yield 2027 * |
1.07% | Yield 2028 * | 1.07% |
| Markets | Quality | ||
|---|---|---|---|
Bombay S.E.
| GLAXO | Delayed | |
NSE India S.E.
| GLAXO | Delayed |
Last Transcript: GlaxoSmithKline Pharmaceuticals Limited
| 1 day | +0.25% | ||
| 1 week | -1.81% | ||
| Current month | +0.25% | ||
| 1 month | -7.35% | ||
| 3 months | +12.63% | ||
| 6 months | +19.37% | ||
| Current year | +12.28% |
| 1 week | 2,725 |  | 2,986.65 |
| 1 month | 2,725 | | 3,074 |
| Current year | 2,088 | | 3,121.1 |
| 1 year | 2,088 | | 3,121.1 |
| 3 years | 1,387.9 | | 3,515.95 |
| 5 years | 1,228 | | 3,515.95 |
| 10 years | 1,020 | | 3,515.95 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bhushan Akshikar
CEO | Chief Executive Officer | 56 | 2022-11-30 |
Ronojit Biswas
DFI | Director of Finance/CFO | - | 2026-03-31 |
Shalini Menon
CTO | Chief Tech/Sci/R&D Officer | - | 2024-07-07 |
| Director | Title | Age | Since |
|---|---|---|---|
Renu Sud Karnad
CHM | Chairman | 73 | 2019-03-31 |
| Director/Board Member | 59 | 2020-05-17 | |
Manu Anand
BRD | Director/Board Member | 67 | 2022-05-15 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.25% | -1.81% | +2.97% | +76.65% | 4.89B | |
| -0.55% | -3.01% | +38.87% | +112.95% | 1,031B | |
| -0.68% | -2.81% | +41.40% | +69.56% | 638B | |
| -0.26% | -1.72% | +6.62% | +75.76% | 462B | |
| -0.71% | -2.18% | +60.61% | +41.16% | 359B | |
| +0.01% | -3.74% | +23.91% | +41.02% | 335B | |
| -1.24% | -0.30% | +14.02% | +27.02% | 273B | |
| -1.39% | -2.11% | -2.40% | +10.85% | 253B | |
| -0.85% | +2.77% | +39.80% | +56.69% | 228B | |
| -0.51% | -0.93% | +33.42% | +100.13% | 185B | |
| Average | -0.66% | -0.71% | +25.92% | +61.18% | 376.87B | |
| Weighted average by Cap. | -0.73% | -0.35% | +31.25% | +70.66% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 42.57B 444M 391M 370M 334M 630M 638M 4.43B 1.71B 21.76B 1.67B 1.63B 69.77B | 47.24B 493M 434M 411M 371M 699M 708M 4.92B 1.89B 24.15B 1.85B 1.81B 77.43B |
| Net income | 11.65B 122M 107M 101M 91.55M 173M 175M 1.21B 467M 5.96B 456M 446M 19.1B | 13.42B 140M 123M 117M 105M 199M 201M 1.4B 538M 6.86B 525M 514M 21.99B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-01 | ₹2,774.50 | +0.25% | 3,797 |
| 26-09-30 | ₹2,767.60 | -0.70% | 2,578 |
| 26-09-29 | ₹2,787.25 | -3.82% | 3,692 |
| 26-09-28 | ₹2,897.85 | +2.88% | 14,107 |
| 26-09-25 | ₹2,816.85 | -0.31% | 639 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GLAXO Stock
Select your edition
All financial news and data tailored to specific country editions
